The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.

UNLABELLED As SPECT/CT technology evolves, its applications and indications need to be evaluated clinically for more efficient and cost-effective use. This retrospective study evaluated the clinical value of simultaneously acquired (99m)Tc-sestamibi SPECT/CT versus conventional SPECT in diagnosing and locating parathyroid adenomas or hyperplasia in patients with primary hyperparathyroidism. METHODS Immediately and 60 minutes after intravenous administration of 740-925 MBq of (99m)Tc-sestamibi, static planar images of the neck and chest were obtained. SPECT/CT images were acquired 30 minutes after injection. Two experienced masked readers independently evaluated whether conventional SPECT images provided information beyond what was available from the planar images either by changing the diagnosis or by better locating the glands and whether the SPECT/CT images provided information beyond what was available from the planar plus conventional SPECT images. Forty-eight consecutive patients with a clinical diagnosis of primary hyperparathyroidism were included in the study. The 32 whose scans showed positive results underwent surgical resection and were examined histopathologically. RESULTS Planar and SPECT imaging, with or without CT fusion, identified 89% of the surgically confirmed diseased parathyroid glands. Use of SPECT/CT changed the diagnosis in only 1 patient (2%) from positive to negative and better located the glands in only 4 patients (8%). SPECT/CT was particularly helpful in locating the 2 ectopic parathyroid adenomas diagnosed in this cohort. Tracer retention in diseased glands did not correlate with histologic characteristics. Also, biochemical markers did not correlate with the scan findings. CONCLUSION SPECT/CT has no significant clinical value additional to that of conventional SPECT for parathyroid imaging except in locating ectopic parathyroid glands. Eliminating the CT acquisition will spare patients the additional time, radiation exposure, and expense.

[1]  S. Jinnouchi,et al.  Parathyroid scintigraphy with 99mTc‐MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography , 2003, Nuclear medicine communications.

[2]  Davide Fiore,et al.  An Ectopic Mediastinal Parathyroid Adenoma Accurately Located by a Single-Day Imaging Protocol of Tc-99m Pertechnetate–MIBI Subtraction Scintigraphy and MIBI-SPECT–Computed Tomographic Image Fusion , 2002, Clinical nuclear medicine.

[3]  A. Aurengo,et al.  Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  K. Kaczirek,et al.  Combined transmission and 99mTc-sestamibi emission tomography for localization of mediastinal parathyroid glands , 2003, Nuklearmedizin.

[5]  T. Helbich,et al.  Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases , 1997, European Journal of Nuclear Medicine.

[6]  N. Perrier,et al.  Experienced Scintigraphers Contribute to Success of Minimally Invasive Parathyroidectomy by Skilled Endocrine Surgeons , 2003, The American surgeon.

[7]  Q. Duh,et al.  Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. , 2003, Journal of the American College of Surgeons.

[8]  M. Pelizzo,et al.  Preoperative localization and radioguided parathyroid surgery. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  M. Ishibashi,et al.  Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  P. Leedman,et al.  Ectopic parathyroid adenoma localised with sestamibi SPECT and image‐fused computed tomography , 2003, The Medical journal of Australia.

[11]  Antonio Cossu,et al.  The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  P. Mikosch,et al.  Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism. , 1997, Investigative radiology.

[13]  M. Lorberboym,et al.  Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  P. Mikosch,et al.  Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area. , 2000, Investigative radiology.

[15]  A. Hernández Mijares,et al.  [Diagnostic value of parathyroid localization techniques in surgery for primary hyperparathyroidism]. , 2003, Acta otorrinolaringologica espanola.

[16]  M. O'Doherty,et al.  99Tcm sestamibi — a new agent for parathyroid imaging , 1989, Nuclear medicine communications.

[17]  H. Gogas,et al.  Pre-operative Tc-99m-Sestamibi Scanning and Intra-Operative Nuclear Mapping: Are they Accurate In Localizing Parathyroid Adenomas ? , 2003, Acta chirurgica Belgica.

[18]  M. Conrad,et al.  Impact of Hypercalcemia and Parathyroid Hormone Level on the Sensitivity of Preoperative Sestamibi Scanning for Primary Hyperparathyroidism , 2003, The American surgeon.

[19]  A. H. Mijares,et al.  Valor diagnóstico de las técnicas de localización paratiroidea en la cirugía del hiperparatiroidismo primario , 2003 .

[20]  I. Sugawara,et al.  Pre-operative localization and tissue uptake study in parathyroid imaging with technetium-99m-sestamibi. , 1999, The Australian and New Zealand journal of surgery.

[21]  N. Perrier,et al.  Enhanced Scintigraphic Protocol Required for Optimal Preoperative Localization Before Targeted Minimally Invasive Parathyroidectomy , 2003, Clinical nuclear medicine.

[22]  ANNE KIRSTINE ARVESCHOUG,et al.  Presurgical Localization of Abnormal Parathyroid Glands Using a Single Injection of Tc-99m Sestamibi: Comparison of High-Resolution Parallel-Hole and Pinhole Collimators, and Interobserver and Intraobserver Variation , 2002, Clinical nuclear medicine.